sb 202190 has been researched along with Cardiac Diseases in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Q | 1 |
| Deng, Y | 2 |
| Lai, W | 1 |
| Guan, X | 1 |
| Sun, X | 1 |
| Han, Q | 1 |
| Wang, F | 1 |
| Pan, X | 1 |
| Ji, Y | 1 |
| Luo, H | 1 |
| Huang, P | 1 |
| Tang, Y | 1 |
| Gu, L | 1 |
| Dan, G | 1 |
| Yu, J | 1 |
| Namaka, M | 1 |
| Zhang, J | 1 |
| Li, X | 1 |
1 other study available for sb 202190 and Cardiac Diseases
| Article | Year |
|---|---|
Maternal inflammation activated ROS-p38 MAPK predisposes offspring to heart damages caused by isoproterenol via augmenting ROS generation.
Topics: Animals; Antioxidants; Female; Heart; Heart Diseases; Imidazoles; Inflammation; Isoproterenol; Male; | 2016 |